Home Page

About Us

Investors

Inventors

Portfolio

Contact Us

Privacy Policy

Our Leadership - Bob Saunders

Bob Saunders

   Bob Saunders
Robert S. Saunders is Retired Managing Director of Chrysalis Ventures, LLC, Kentucky’s largest venture capital fund. Mr. Saunders previously was Chief Planning Officer and Managing Director for Strategic Planning and Business Development at Providian Capital Management, Inc. Mr. Saunders began his career in 1978 as a business strategy consultant at The Boston Consulting Group and joined Bain & Co. in 1982, where he became acting Director of Competitive Strategy Analysis. Mr. Saunders holds a B.A. from Stanford University, an M.S. from the London School of Economics and an M.A. from Harvard University.







July 16, 2010
Intrepid Bioinformatics Receives Investment, Meets Milestones

May 6, 2010
MetaCyte Business Lab Receives Mention in Nature (PDF)

March 31, 2010
MetaCyte Recognized for Innovation

March 15, 2010
Teresa Leezer Honored a Second Time for Excellence in Business Management

February 23, 2010
Gailar Addresses Leaders as Part of Innovation Panel

January 2010
Triathlon Medical Ventures and the Kentucky Seed Capital Fund Lead Investment in Louisville Start-Up

November 2009
MetaCyte Advisor Bill Strench Featured in Business First (External Link)

November 2009
EndoProtech Awarded $270,000 from Kentucky Cabinet for Economic Development

August 25, 2009
Pierce Named Interim Head of UofL Research (External Link)

July 1, 2009
AllTranz Named Top Innovator by National Venture Group

May 8, 2009
ApoImmune Finalist for "Best Early-Stage Vaccine Biotech" at World Vaccine Congress ViE Awards

September 12, 2008
MetaCyte Team Shows Off New Offices

June 18, 2008
Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

Summer 2006
A UofL research team led by Fred Roisen, Ph.D., has developed a breakthrough adult stem-cell therapy that repairs spinal-cord damage in paralyzed rats (External Link)